What Happens When A Blind Person Takes Psychedelics?
Last reviewed and updated: June 30, 2026.
Key Takeaways
| Congenitally blind | No visual cortex circuitry for imagery → no visual hallucinations; but full range of other effects: enhanced tactile, emotional intensity, synesthesia, ego dissolution |
| Late-blind | Retained visual cortex wiring from sighted years → often DO experience visual hallucinations, confirming the endogenous-imagery theory |
| What this proves | Psychedelic visuals come from the brain generating imagery from internal templates, not from external input — explains why set and setting shapes visual content |
| Therapeutic effects | Emotional processing, ego dissolution, and insight appear similar regardless of visual experience — visuals are not the therapeutic driver |
| Research implication | Visual intensity ≠ therapeutic outcome; supports non-psychoactive psychedelic analog research (tabernanthalog, BDNF agonists) |
For people with vision, taking psychedelics often brings a mix of vibrant, bright colors and shapes. But what happens when a blind person takes psychedelics? For those without the ability to see, does a similar psychedelic experience occur?
While we’ve written about what causes visuals in psychedelic trips before, many people are probably wondering how (or if) that differs in people who are blind. Without the ability to see, how effective are psychedelics?
To help answer what happens when a blind person takes psychedelics, Healing Maps’ resident neuroscientist, Zeus Tipado, dives into the topic. As Zeus explains, not all blindness is created equally, with the brain functioning differently for millions of people.
The video below — available on Healing Maps’ YouTube channel — goes into better detail about the psychedelic experience for blind people.
Referencing a study published in the journal Consciousness and Cognition in 2018 — where a blind participant took LSD mixed with cannabis to see the effects — the video focuses on something called synesthesia.
RELATED: What Will Psychedelics Look Like In The Future?
Details About What Happens When A Blind Person Takes Psychedelics
As for the participant from the study, he described his psychedelic experience as follows, per PsyPost:
“Every time I did acid, I experienced something new and spectacular. Obviously through the senses which are available to me! I never had any visual images come to me. I can’t see or imagine what light or dark might look like. With LSD and cannabis though, I experienced so much through my hearing, touch and emotions that it was already enough for me to take!”
…
“During my psychedelic experiences, whenever I listened to music, I felt as if I was immersed in the most beautiful waterfall ever. The episode of the waterfall was the nearest I ever came to experiencing anything like synesthesia. The music of Bach’s third Brandenburg concerto brought on the waterfall effect… “The sounds coming from songs I would normally listen to became three dimensional, deep and delayed. It seemed that music began coming apart and unravelling.”
So, although blind people or those with impaired vision can’t see, we now have a much clearer idea about what happens when a blind person takes psychedelics.
Check out more information on psychedelics by following Healing Maps on YouTube, Instagram and Facebook.
What the Neuroscience of Blind Psychedelic Experience Reveals About How Visuals Actually Work
The question of what a blind person experiences on psychedelics turns out to be one of the most neuroscientifically revealing questions you can ask about how these substances work. The short answer — established through case reports, interviews, and several small studies — is that it depends on when the person lost their sight. People who were born blind (congenitally blind) or who lost their vision in early childhood, before the visual cortex developed normal visual processing circuitry, generally do not experience visual hallucinations on psychedelics. Their visual cortex has not developed the architecture to generate visual imagery. People who lost their sight later in life, after having developed visual memories and the neural circuitry to process them, often do experience visual hallucinations on psychedelics — sometimes vividly so. Their visual cortex retains the wiring; psychedelics activate it.
This pattern is enormously informative about the mechanism underlying psychedelic visuals. The dominant theory in contemporary psychedelic neuroscience is the “entropic brain” or “endogenous imagery” model: psychedelics (via 5-HT2A receptor agonism) disrupt the thalamus’s normal role as a sensory gating mechanism, reducing top-down filtering and allowing the brain’s own internally generated pattern-templates and imagery to flood into conscious experience. The visual cortex, in this model, is not processing external visual input when it generates psychedelic visuals — it is generating imagery from internal templates derived from memory, learning, and prior visual experience. The fact that congenitally blind people don’t see psychedelic visuals (their visual cortex has no such templates) while late-blind people do (their cortex retains stored templates) is strong evidence for this model. Psychedelic visuals are the brain’s own internal imagery, not a distortion of external perception.
Both groups — congenitally blind and late-blind — report a full range of non-visual psychedelic effects. Enhanced tactile sensations (textures feeling more vivid, surfaces feeling different, temperature sensitivity altered). Altered time perception. Increased emotional intensity. Synesthesia (sound producing tactile sensations, or having perceived “colors” or qualities that are not visual in the conventional sense but seem to carry visual-like information through other sensory channels). Ego dissolution. Profound shifts in sense of self and identity. Emotional catharsis. The experiential depth of a psychedelic experience — the sense that something significant has happened — is consistently reported by blind users. Visual hallucinations are not a prerequisite for a psychedelically meaningful experience.
The therapeutic implications of this research are significant and underappreciated. Most of the early popular framing of psychedelic therapy emphasized the visual experience — the visions, the imagery, the “trip” in the colloquial sense. But if blind people show comparable therapeutic responses (emotional processing, insight, ego dissolution, long-term shifts in mood and perspective) without visual experience, that is strong evidence that the therapeutic mechanism of psychedelic-assisted therapy does not depend on visual hallucinations. This supports a growing body of research suggesting that visual intensity does not predict therapeutic outcome: the emotionally and neuroplastically relevant effects of psychedelics are largely independent of the visual component. It also provides early theoretical support for the non-psychoactive analog research direction — compounds like tabernanthalog or BDNF-pathway agonists that attempt to capture the neuroplastic and antidepressant effects of psychedelics without the perceptual disruption. If a blind person can have a therapeutically effective psychedelic experience without visual hallucinations, the perceptual experience may be less central to efficacy than once assumed.
Frequently Asked Questions
Do blind people see visuals on psychedelics?
It depends on when they lost their sight. People who are congenitally blind (blind from birth) or who lost vision in very early childhood generally do not experience visual hallucinations on psychedelics. The visual cortex in these individuals has not developed the circuitry for visual processing, so there are no stored visual templates for the brain to activate or amplify. People who lost their vision later in life — after years of sighted experience — often do experience visual hallucinations on psychedelics, sometimes quite vivid ones. Their visual cortex retains the wiring and stored templates built during the years of sighted experience; psychedelics can activate this retained architecture. This distinction is one of the clearest pieces of evidence for the endogenous imagery theory: that psychedelic visuals come from the brain generating imagery from internal templates, not from distorting external perception.
What do blind people experience on psilocybin?
Blind users — both congenitally blind and late-blind — consistently report a full range of non-visual psychedelic effects. Enhanced tactile sensations: surfaces, textures, and temperatures feel more vivid or qualitatively different than usual. Altered time perception: time may feel stretched, compressed, or lose its normal linear quality. Increased emotional intensity: emotions feel more present, more available, sometimes overwhelming. Synesthesia: sounds may produce tactile sensations or carry what seem like spatial or “color-like” qualities that are processed through non-visual channels. Ego dissolution: the ordinary sense of being a separate self with clear boundaries becomes permeable or disappears entirely. Profound insight, emotional catharsis, and a sense that the experience was meaningful or significant are commonly reported regardless of whether visual hallucinations occurred. Late-blind individuals additionally may experience visual imagery; congenitally blind individuals typically do not, but the non-visual phenomenology appears similar in depth and therapeutic relevance.
What does this tell us about how psychedelic visuals work?
The pattern of visual experience in blind psychedelic users is strong evidence for the endogenous imagery theory of psychedelic visuals. This theory holds that psychedelics (via 5-HT2A receptor agonism) disrupt the thalamus’s normal role as a sensory filter, reducing top-down suppression and allowing the brain to surface its own internally generated imagery — patterns, templates, and visual memories built from prior experience. Congenitally blind people have no such stored visual templates (their visual cortex developed without visual input), so no visual hallucinations emerge. Late-blind people have extensive stored templates (built during years of sighted life), so psychedelics can activate them. This model explains several other observations: why psychedelic visuals are shaped by personal history, culture, and set and setting; why some people see geometric patterns while others see narrative scenes; and why visual content often feels personally or symbolically meaningful rather than random. The visual cortex, under psychedelics, is generating from the inside out — not distorting input from the outside in.
Can blind people benefit from psychedelic therapy?
Yes, based on available evidence. The therapeutic effects of psychedelic-assisted therapy — emotional processing, reduction in depression and anxiety symptoms, ego dissolution, insight, increased psychological flexibility — appear to be comparable in blind individuals regardless of whether visual hallucinations occur. This is a clinically important finding: it suggests the therapeutic mechanism of psychedelics is not mediated by visual experience. The non-visual effects — emotional intensity, altered self-perception, dissolution of defensive mental structures — appear to be the therapeutically active components, with visual hallucinations being a co-occurring but not causally necessary element. This has implications beyond blind patients: it supports the theoretical basis for non-psychoactive psychedelic analogs (compounds designed to produce the neuroplastic and emotional effects without the visual disruption), and it suggests that patients who do not have vivid visual experiences on psychedelics are not getting a “lesser” treatment. The visual dimension of the psychedelic experience, while often profound and meaningful, does not appear to be the driver of therapeutic outcome.
